TrialLancet (London, England)2022

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.

Sue Ann Costa Clemens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.